J 2020

Lactic Acidosis Interferes With Toxicity of Perifosine to Colorectal Cancer Spheroids: Multimodal Imaging Analysis

PAVLATOVSKÁ, Barbora, Markéta MACHÁLKOVÁ, Petra BRISUDOVÁ, Adam PRUŠKA, Karel ŠTĚPKA et. al.

Basic information

Original name

Lactic Acidosis Interferes With Toxicity of Perifosine to Colorectal Cancer Spheroids: Multimodal Imaging Analysis

Authors

PAVLATOVSKÁ, Barbora (203 Czech Republic, belonging to the institution), Markéta MACHÁLKOVÁ (203 Czech Republic, belonging to the institution), Petra BRISUDOVÁ (703 Slovakia, belonging to the institution), Adam PRUŠKA, Karel ŠTĚPKA (203 Czech Republic, belonging to the institution), Jan MICHÁLEK (203 Czech Republic, belonging to the institution), Tereza NEČASOVÁ (203 Czech Republic, belonging to the institution), Petr BENEŠ (203 Czech Republic, belonging to the institution), Jan ŠMARDA (203 Czech Republic, belonging to the institution), Jan PREISLER (203 Czech Republic, belonging to the institution), Michal KOZUBEK (203 Czech Republic, belonging to the institution) and Jarmila NAVRÁTILOVÁ (203 Czech Republic, guarantor, belonging to the institution)

Edition

Frontiers in Oncology, Lausanne, Frontiers Media S.A. 2020, 2234-943X

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

10608 Biochemistry and molecular biology

Country of publisher

Switzerland

Confidentiality degree

není předmětem státního či obchodního tajemství

References:

Impact factor

Impact factor: 6.244

RIV identification code

RIV/00216224:14310/20:00117367

Organization unit

Faculty of Science

UT WoS

000599610600001

Keywords in English

perifosine; Akt kinase; tumor environment; lactic acidosis; alkalization; signal co-registration; mass spectrometry imaging; colorectal cancer

Tags

International impact, Reviewed
Změněno: 14/1/2021 13:37, Mgr. Marie Šípková, DiS.

Abstract

V originále

Colorectal cancer (CRC) is a disease with constantly increasing incidence and highmortality. The treatment efficacy could be curtailed by drug resistance resulting from poordrug penetration into tumor tissue and the tumor-specific microenvironment, such ashypoxia and acidosis. Furthermore, CRC tumors can be exposed to different pHdepending on the position in the intestinal tract. CRC tumors often share upregulationof the Akt signaling pathway. In this study, we investigated the role of external pH in controlof cytotoxicity of perifosine, the Akt signaling pathway inhibitor, to CRC cells using 2D and3D tumor models. In 3D settings, we employed an innovative strategy for simultaneousdetection of spatial drug distribution and biological markers of proliferation/apoptosisusing a combination of mass spectrometry imaging and immunohistochemistry. In 3Dconditions, low and heterogeneous penetration of perifosine into the inner parts of thespheroids was observed. The depth of penetration depended on the treatment durationbut not on the external pH. However, pH alteration in the tumor microenvironment affectedthe distribution of proliferation- and apoptosis-specific markers in the perifosine-treatedspheroid. Accurate co-registration of perifosine distribution and biological response in thesame spheroid section revealed dynamic changes in apoptotic and proliferative markersoccurring not only in the perifosine-exposed cells, but also in the perifosine-free regions.Cytotoxicity of perifosine to both 2D and 3D cultures decreased in an acidic environmentbelow pH 6.7. External pH affects cytotoxicity of the other Akt inhibitor, MK-2206, in asimilar way. Our innovative approach for accurate determination of drug efficiency in 3Dtumor tissue revealed that cytotoxicity of Akt inhibitors to CRC cells is strongly dependenton pH of the tumor microenvironment. Therefore, the effect of pH should be consideredduring the design and pre-clinical/clinical testing of the Akt-targeted cancer therapy.

Links

EF16_013/0001775, research and development project
Name: Modernizace a podpora výzkumných aktivit národní infrastruktury pro biologické a medicínské zobrazování Czech-BioImaging
LM2018129, research and development project
Name: Národní infrastruktura pro biologické a medicínské zobrazování Czech-BioImaging
Investor: Ministry of Education, Youth and Sports of the CR
LQ1601, research and development project
Name: CEITEC 2020 (Acronym: CEITEC2020)
Investor: Ministry of Education, Youth and Sports of the CR
MUNI/A/1127/2019, interní kód MU
Name: Podpora výzkumné činnosti studentů molekulární biologie a genetiky 8 (Acronym: MBG 8)
Investor: Masaryk University, Category A
MUNI/G/0974/2016, interní kód MU
Name: Optimalizace cílené terapie kolorektálního karcinomu ovlivňováním účinnosti penetrace a cytotoxicity regulátorů buněčných signalizací
Investor: Masaryk University, INTERDISCIPLINARY - Interdisciplinary research projects